160 related articles for article (PubMed ID: 37578057)
1. Diagnosis and management of pulmonary veno-occlusive disease.
Solinas S; Boucly A; Beurnier A; Kularatne M; Grynblat J; Eyries M; Dorfmüller P; Sitbon O; Humbert M; Montani D
Expert Rev Respir Med; 2023; 17(8):635-649. PubMed ID: 37578057
[TBL] [Abstract][Full Text] [Related]
2. Clinical phenotypes and outcomes of heritable and sporadic pulmonary veno-occlusive disease: a population-based study.
Montani D; Girerd B; Jaïs X; Levy M; Amar D; Savale L; Dorfmüller P; Seferian A; Lau EM; Eyries M; Le Pavec J; Parent F; Bonnet D; Soubrier F; Fadel E; Sitbon O; Simonneau G; Humbert M
Lancet Respir Med; 2017 Feb; 5(2):125-134. PubMed ID: 28087362
[TBL] [Abstract][Full Text] [Related]
3. Pulmonary veno-occlusive disease: illustrative cases and literature review.
Lechartier B; Boucly A; Solinas S; Gopalan D; Dorfmüller P; Radonic T; Sitbon O; Montani D
Eur Respir Rev; 2024 Jan; 33(171):. PubMed ID: 38232988
[TBL] [Abstract][Full Text] [Related]
4. Good response to pulmonary arterial hypertension-targeted therapy in 2 pulmonary veno-occlusive disease patients: A case report.
Zhang L; Wang Y; Zhang R
Medicine (Baltimore); 2021 Oct; 100(41):e27334. PubMed ID: 34731104
[TBL] [Abstract][Full Text] [Related]
5. Pulmonary veno-occlusive disease.
Montani D; Lau EM; Dorfmüller P; Girerd B; Jaïs X; Savale L; Perros F; Nossent E; Garcia G; Parent F; Fadel E; Soubrier F; Sitbon O; Simonneau G; Humbert M
Eur Respir J; 2016 May; 47(5):1518-34. PubMed ID: 27009171
[TBL] [Abstract][Full Text] [Related]
6. Pulmonary veno-occlusive disease: pathogenesis, risk factors, clinical features and diagnostic algorithm - state of the art.
Szturmowicz M; Kacprzak A; Szołkowska M; Burakowska B; Szczepulska E; Kuś J
Adv Respir Med; 2018; 86(3):. PubMed ID: 29960280
[TBL] [Abstract][Full Text] [Related]
7. Lipidomic Profile Analysis of Lung Tissues Revealed Lipointoxication in Pulmonary Veno-Occlusive Disease.
Khoury S; Beauvais A; Colas J; Saint-Martin Willer A; Perros F; Humbert M; Vandebrouck C; Montani D; Ferreira T; Antigny F
Biomolecules; 2022 Dec; 12(12):. PubMed ID: 36551306
[TBL] [Abstract][Full Text] [Related]
8. [Pulmonary veno-occlusive disease].
Boucly A; Girerd B; Bourlier D; Nemlaghi S; Caliez J; Savale L; Jaïs X; Dorfmüller P; Simonneau G; Sitbon O; Humbert M; Montani D
Rev Mal Respir; 2018 Feb; 35(2):160-170. PubMed ID: 29501213
[TBL] [Abstract][Full Text] [Related]
9. Unique wreath-like smooth muscle proliferation of the pulmonary vasculature in pulmonary veno-occlusive disease versus pulmonary arterial hypertension.
Lai YJ; Chen PR; Huang YL; Hsu HH
J Formos Med Assoc; 2020 Jan; 119(1 Pt 2):300-309. PubMed ID: 31202500
[TBL] [Abstract][Full Text] [Related]
10. Pulmonary vascular remodeling patterns and expression of general control nonderepressible 2 (GCN2) in pulmonary veno-occlusive disease.
Nossent EJ; Antigny F; Montani D; Bogaard HJ; Ghigna MR; Lambert M; Thomas de Montpréville V; Girerd B; Jaïs X; Savale L; Mercier O; Fadel E; Soubrier F; Sitbon O; Simonneau G; Vonk Noordegraaf A; Humbert M; Perros F; Dorfmüller P
J Heart Lung Transplant; 2018 May; 37(5):647-655. PubMed ID: 29108819
[TBL] [Abstract][Full Text] [Related]
11. Pulmonary Capillary Hemangiomatosis and Pulmonary Veno-occlusive Disease.
Chaisson NF; Dodson MW; Elliott CG
Clin Chest Med; 2016 Sep; 37(3):523-34. PubMed ID: 27514598
[TBL] [Abstract][Full Text] [Related]
12. Rapid disease progress in a PVOD patient carrying a novel EIF
Zeng X; Chen F; Rathinasabapathy A; Li T; Adnan Ali Mohammed Mohammed A; Yu Z
BMC Pulm Med; 2020 Jul; 20(1):186. PubMed ID: 32631303
[TBL] [Abstract][Full Text] [Related]
13. Good response to PAH-targeted drugs in a PVOD patient carrying Biallelic EIF2AK4 mutation.
Liang L; Su H; Ma X; Zhang R
Respir Res; 2018 Oct; 19(1):192. PubMed ID: 30285736
[TBL] [Abstract][Full Text] [Related]
14. Pulmonary veno-occlusive disease as a cause of severe pulmonary hypertension in a dog.
den Toom ML; Grinwis G; van Suylen RJ; Boroffka SA; de Jong P; van Steenbeek FG; Szatmári V
Acta Vet Scand; 2018 Dec; 60(1):78. PubMed ID: 30518401
[TBL] [Abstract][Full Text] [Related]
15. Case report: pulmonary veno-occlusive disease: a rare but fatal cause of pulmonary hypertension in a patient following allogeneic stem cell transplantation.
Katrien M; Dieter S; Anke D; Amelie D; De Pauw M; Eric D
Acta Clin Belg; 2022 Jun; 77(3):697-702. PubMed ID: 34191691
[TBL] [Abstract][Full Text] [Related]
16. Occupational exposure to organic solvents: a risk factor for pulmonary veno-occlusive disease.
Montani D; Lau EM; Descatha A; Jaïs X; Savale L; Andujar P; Bensefa-Colas L; Girerd B; Zendah I; Le Pavec J; Seferian A; Perros F; Dorfmüller P; Fadel E; Soubrier F; Sitbon O; Simonneau G; Humbert M
Eur Respir J; 2015 Dec; 46(6):1721-31. PubMed ID: 26541523
[TBL] [Abstract][Full Text] [Related]
17. Pulmonary veno-occlusive disease in Sjogren's syndrome: a case report.
Zeng X; Liu Q; Rathinasabapathy A; Zha L; Liu D; Tang Y; Sun J; Luo H; Yu Z
BMC Pulm Med; 2023 Jan; 23(1):26. PubMed ID: 36653758
[TBL] [Abstract][Full Text] [Related]
18. [Familial pulmonary veno-occlusive disease with a composite biallelic heterozygous EIF2AK4 mutation].
Treffel G; Guillaumot A; Gomez E; Eyries M; Petit I; Chabot JF; Chaouat A
Rev Mal Respir; 2020 Dec; 37(10):823-828. PubMed ID: 33071063
[TBL] [Abstract][Full Text] [Related]
19. EIF2AK4 mutations cause pulmonary veno-occlusive disease, a recessive form of pulmonary hypertension.
Eyries M; Montani D; Girerd B; Perret C; Leroy A; Lonjou C; Chelghoum N; Coulet F; Bonnet D; Dorfmüller P; Fadel E; Sitbon O; Simonneau G; Tregouët DA; Humbert M; Soubrier F
Nat Genet; 2014 Jan; 46(1):65-9. PubMed ID: 24292273
[TBL] [Abstract][Full Text] [Related]
20. Pulmonary veno-occlusive disease.
Montani D; Price LC; Dorfmuller P; Achouh L; Jaïs X; Yaïci A; Sitbon O; Musset D; Simonneau G; Humbert M
Eur Respir J; 2009 Jan; 33(1):189-200. PubMed ID: 19118230
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
